Ipsen SA
119.40
15-9月-25 06:41:08
15 分の遅延
株式
+0.40
+0.34%
本日の幅
118.85 - 120.00
ISIN
FR0010259150
ソース
Cboe
-
11 9 2025 09:00:00 提供 Nasdaq GlobeNewswire
-
IPSEN - Buy-back programme - Art 5 of MAR - Week 36 - 2025
09 9 2025 09:00:00 提供 Nasdaq GlobeNewswire
-
IPSEN - Buy-back programme - Art 5 of MAR - Week 35 - 2025
02 9 2025 09:00:00 提供 Nasdaq GlobeNewswire
-
IPSEN - Buy-back programme - Art 5 of MAR - Week 34 - 2025
29 8 2025 09:00:00 提供 Nasdaq GlobeNewswire
-
27 8 2025 09:00:00 提供 Nasdaq GlobeNewswire
-
IPSEN - Buy-back programme - Art 5 of MAR - Week 33 - 2025
19 8 2025 09:00:00 提供 Nasdaq GlobeNewswire
-
IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2025
12 8 2025 09:00:00 提供 Nasdaq GlobeNewswire
-
IPSEN - Buy-back programme - Art 5 of MAR - Week 31 - 2025
05 8 2025 09:00:00 提供 Nasdaq GlobeNewswire
-
Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025)
31 7 2025 09:00:00 提供 Nasdaq GlobeNewswire
-
Ipsen delivers strong results in the first half of 2025 and upgrades its full-year guidance
30 7 2025 22:00:00 提供 Nasdaq GlobeNewswire
-
IPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2025
29 7 2025 09:00:00 提供 Nasdaq GlobeNewswire
-
Cabometyx® approved in the EU for previously treated advanced neuroendocrine tumors
24 7 2025 10:41:23 提供 Nasdaq GlobeNewswire
-
Ipsen announces changes to its Executive Committee
22 7 2025 22:30:00 提供 Nasdaq GlobeNewswire
-
IPSEN - Buy-back programme - Art 5 of MAR - Week 29 - 2025
22 7 2025 09:00:00 提供 Nasdaq GlobeNewswire
-
IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2025
16 7 2025 09:00:00 提供 Nasdaq GlobeNewswire
-
10 7 2025 09:30:00 提供 Nasdaq GlobeNewswire
-
IPSEN - Buy-back programme - Art 5 of MAR - Week 27- 2025
08 7 2025 09:00:00 提供 Nasdaq GlobeNewswire
-
Ipsen - Half year statement - 2025 06 30
07 7 2025 09:00:00 提供 Nasdaq GlobeNewswire
-
IPSEN - Buy-back programme - Art 5 of MAR - Week 26 - 2025
01 7 2025 09:00:00 提供 Nasdaq GlobeNewswire
-
IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2025
24 6 2025 09:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >